Oncology Drugs Market projected to reach valuation in USD million by 2024


Posted November 22, 2018 by aupare19

Axiommrc added Oncology Drugs Market Report, By Therapeutic Modules, Cancer Type and Geography – Global Market Share, Trend Analysis and Forecast up to 2024

 
Oncology Drugs Market: Introduction
Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy.
Oncology Drugs Market: Analysis
The global oncology drugs market revenue is estimated to reach USD 202.13 Billion by 2024 expanding at a CAGR of 7.8% from 2019 to 2024. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types.
The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars.
Get the Sample Report: http://bit.ly/2zlwzkq
Developed nations have implemented strict regulations for the design and development of cancer drugs. USFDA and European Union have undertaken significant initiatives to fuel the growth of the cancer drugs market by providing pre-market approval for potential drugs under clinical development.
However, the high cost of drug development, the threat of failure and the adverse effects of cancer drug therapy, particularly chemotherapy, hinders the market growth.
Oncology Drugs Market: Geography
By geography, the market is fragmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. North America is anticipated to remain the leading region over the forecast period from 2018 to 2024. Demand for cancer drugs was highest in North America especially in the U.S.
Browser for more: http://bit.ly/2FE8laH
Oncology Drugs Market: Top Key Players
Some of the key players operating in the oncology drugs market with most significant product development include and are not limited to Amgen Inc, Takeda Oncology, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson and Johnson, Merck & Company, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals and among others.
Visit Our Company Profile: http://bit.ly/2Aud3Dz
Media Contact:
Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: [email protected]
Tel: +1(845)875-9786, +44(0) 20 23869707
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By axiommrc
Phone 8458759786
Business Address 616 Corporate Way, Suite 2-4268 Valley Cottage, NY 10989
www.axiommrc.com
Country United States
Categories Health
Tags oncology drugs , oncology drugs market , oncology drugs market analysis , oncology drugs market growth , oncology drugs market outlook , oncology drugs market share , oncology drugs market size , oncology drugs market trends
Last Updated November 22, 2018